LINACS
LINACS Home
OligoCare
Group

CDK4/6 inhibitor

The data below refer to patients treated with CDK4/6 inhibitor as the sole drug class, excluding any concurrent use of drugs from other groups.
Location
Treated site
Individual Drugs

Select a drug to view its individual evidence base (drug + SBRT, no other concurrent systemic drugs). Drugs without available data are shown greyed out.

Palbociclib
Abemaciclib
No data
Ribociclib
No data